Verastem, Inc. (VSTM)
NASDAQ: VSTM · IEX Real-Time Price · USD
10.36
+0.38 (3.81%)
At close: May 2, 2024, 4:00 PM
10.11
-0.25 (-2.41%)
Pre-market: May 3, 2024, 8:00 AM EDT

Verastem Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
73
Market Cap
262.06M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20230--
Dec 31, 20222.60M543.00K26.45%
Dec 31, 20212.05M-86.46M-97.68%
Dec 31, 202088.52M71.06M407.08%
Dec 31, 201917.46M-9.26M-34.67%
Dec 31, 201826.72M--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Dec 31, 20120--
Dec 31, 20110--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bioventus 512.35M
Sharecare 445.25M
23andMe Holding Co. 247.99M
Puma Biotechnology 235.64M
Agenus 156.31M
Senseonics Holdings 22.39M
Fennec Pharmaceuticals 21.25M
AC Immune 17.62M
Revenue Rankings